Annual CFI
$528.00 K
+$540.00 K+4500.00%
December 1, 2023
Summary
- As of February 6, 2025, CSCI annual cash flow from investing activities is $528.00 thousand, with the most recent change of +$540.00 thousand (+4500.00%) on December 1, 2023.
- During the last 3 years, CSCI annual CFI has risen by +$472.00 thousand (+842.86%).
- CSCI annual CFI is now -98.74% below its all-time high of $42.00 million, reached on December 1, 2008.
Performance
CSCI Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFI
$83.00 K
-$25.80 M-99.68%
September 1, 2024
Summary
- As of February 6, 2025, CSCI quarterly cash flow from investing activities is $83.00 thousand, with the most recent change of -$25.80 million (-99.68%) on September 1, 2024.
- Over the past year, CSCI quarterly CFI has increased by +$687.30 thousand (+113.73%).
- CSCI quarterly CFI is now -99.68% below its all-time high of $25.88 million, reached on June 1, 2024.
Performance
CSCI Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFI
$24.79 M
+$133.00 K+0.54%
September 1, 2024
Summary
- As of February 6, 2025, CSCI TTM cash flow from investing activities is $24.79 million, with the most recent change of +$133.00 thousand (+0.54%) on September 1, 2024.
- Over the past year, CSCI TTM CFI has increased by +$25.53 million (+3453.81%).
- CSCI TTM CFI is now at all-time high.
Performance
CSCI TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
CSCI Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +4500.0% | +113.7% | +3453.8% |
| 3 y3 years | +842.9% | +113.7% | +3453.8% |
| 5 y5 years | +1608.6% | +113.7% | +3453.8% |
CSCI Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +180.2% | -99.7% | +113.7% | at high | +2049.9% |
| 5 y | 5-year | at high | +180.2% | -99.7% | +113.7% | at high | +2049.9% |
| alltime | all time | -98.7% | +100.5% | -99.7% | +100.4% | at high | +232.6% |
COSCIENS Biopharma Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $83.00 K(-99.7%) | $24.79 M(+0.5%) |
| Jun 2024 | - | $25.88 M(-4693.4%) | $24.66 M(-2039.4%) |
| Mar 2024 | - | -$563.40 K(-6.8%) | -$1.27 M(+72.0%) |
| Dec 2023 | $528.00 K(-4500.0%) | -$604.30 K(+1108.6%) | -$739.30 K(+400.2%) |
| Sep 2023 | - | -$50.00 K(-7.2%) | -$147.80 K(-0.3%) |
| Jun 2023 | - | -$53.90 K(+73.3%) | -$148.20 K(+10.2%) |
| Mar 2023 | - | -$31.10 K(+143.0%) | -$134.50 K(-53.1%) |
| Dec 2022 | -$12.00 K(-98.2%) | -$12.80 K(-74.6%) | -$286.50 K(-26.6%) |
| Sep 2022 | - | -$50.40 K(+25.4%) | -$390.30 K(-19.1%) |
| Jun 2022 | - | -$40.20 K(-78.0%) | -$482.30 K(-1.6%) |
| Mar 2022 | - | -$183.10 K(+57.0%) | -$490.00 K(-21.0%) |
| Dec 2021 | -$658.00 K(-1275.0%) | -$116.60 K(-18.1%) | -$620.10 K(-14.8%) |
| Sep 2021 | - | -$142.40 K(+197.3%) | -$727.70 K(+7.6%) |
| Jun 2021 | - | -$47.90 K(-84.7%) | -$676.00 K(-0.4%) |
| Mar 2021 | - | -$313.20 K(+39.7%) | -$678.70 K(+78.7%) |
| Dec 2020 | $56.00 K(+12.0%) | -$224.20 K(+147.2%) | -$379.70 K(+62.3%) |
| Sep 2020 | - | -$90.70 K(+79.2%) | -$234.00 K(+52.9%) |
| Jun 2020 | - | -$50.60 K(+256.3%) | -$153.00 K(+37.1%) |
| Mar 2020 | - | -$14.20 K(-81.9%) | -$111.60 K(-26.0%) |
| Dec 2019 | $50.00 K(-242.9%) | -$78.50 K(+709.3%) | -$150.90 K(-22.8%) |
| Sep 2019 | - | -$9700.00(+5.4%) | -$195.40 K(-56.3%) |
| Jun 2019 | - | -$9200.00(-82.8%) | -$447.50 K(-41.2%) |
| Mar 2019 | - | -$53.50 K(-56.5%) | -$761.10 K(-25.0%) |
| Dec 2018 | -$35.00 K(-111.4%) | -$123.00 K(-53.0%) | -$1.01 M(-51.0%) |
| Sep 2018 | - | -$261.80 K(-18.9%) | -$2.07 M(-14.4%) |
| Jun 2018 | - | -$322.80 K(+5.0%) | -$2.42 M(-18.1%) |
| Mar 2018 | - | -$307.30 K(-74.0%) | -$2.96 M(-18.8%) |
| Dec 2017 | $307.00 K(-197.8%) | -$1.18 M(+93.3%) | -$3.64 M(+17.3%) |
| Sep 2017 | - | -$610.50 K(-28.9%) | -$3.11 M(-16.6%) |
| Jun 2017 | - | -$858.50 K(-13.6%) | -$3.73 M(-11.5%) |
| Mar 2017 | - | -$993.80 K(+54.3%) | -$4.21 M(-7.4%) |
| Dec 2016 | -$314.00 K(-134.4%) | -$644.20 K(-47.6%) | -$4.55 M(-4.6%) |
| Sep 2016 | - | -$1.23 M(-8.5%) | -$4.77 M(+13.3%) |
| Jun 2016 | - | -$1.34 M(+1.0%) | -$4.21 M(+23.0%) |
| Mar 2016 | - | -$1.33 M(+53.9%) | -$3.42 M(+36.5%) |
| Dec 2015 | $913.00 K(-1596.7%) | -$864.50 K(+29.5%) | -$2.51 M(+22.3%) |
| Sep 2015 | - | -$667.80 K(+19.8%) | -$2.05 M(+12.0%) |
| Jun 2015 | - | -$557.50 K(+34.0%) | -$1.83 M(-34.4%) |
| Mar 2015 | - | -$416.00 K(+1.9%) | -$2.79 M(-25.8%) |
| Dec 2014 | -$61.00 K(-317.9%) | -$408.40 K(-8.9%) | -$3.76 M(-20.8%) |
| Sep 2014 | - | -$448.40 K(-70.5%) | -$4.74 M(-0.9%) |
| Jun 2014 | - | -$1.52 M(+9.6%) | -$4.79 M(+43.1%) |
| Mar 2014 | - | -$1.38 M(-0.7%) | -$3.34 M(+52.1%) |
| Dec 2013 | $28.00 K(-110.3%) | -$1.39 M(+185.0%) | -$2.20 M(+152.9%) |
| Sep 2013 | - | -$489.20 K(+542.0%) | -$869.10 K(+110.2%) |
| Jun 2013 | - | -$76.20 K(-68.1%) | -$413.40 K(+8.1%) |
| Mar 2013 | - | -$238.60 K(+266.5%) | -$382.60 K(+56.0%) |
| Dec 2012 | -$272.00 K(-111.0%) | -$65.10 K(+94.3%) | -$245.20 K(+5.0%) |
| Sep 2012 | - | -$33.50 K(-26.2%) | -$233.50 K(+2.3%) |
| Jun 2012 | - | -$45.40 K(-55.1%) | -$228.20 K(+18.1%) |
| Mar 2012 | - | -$101.20 K(+89.5%) | -$193.20 K(+40.0%) |
| Dec 2011 | $2.46 M(-5026.0%) | -$53.40 K(+89.4%) | -$138.00 K(-1.5%) |
| Sep 2011 | - | -$28.20 K(+171.2%) | -$140.10 K(-1.7%) |
| Jun 2011 | - | -$10.40 K(-77.4%) | -$142.50 K(+8.0%) |
| Mar 2011 | - | -$46.00 K(-17.1%) | -$131.90 K(+44.9%) |
| Dec 2010 | -$50.00 K | -$55.50 K(+81.4%) | -$91.00 K(+105.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2010 | - | -$30.60 K(<-9900.0%) | -$44.40 K(+11.8%) |
| Jun 2010 | - | $200.00(-103.9%) | -$39.70 K(-19.3%) |
| Mar 2010 | - | -$5100.00(-42.7%) | -$49.20 K(-1.2%) |
| Dec 2009 | -$1.10 M(-102.6%) | -$8900.00(-65.6%) | -$49.80 K(+311.6%) |
| Sep 2009 | - | -$25.90 K(+178.5%) | -$12.10 K(-57.8%) |
| Jun 2009 | - | -$9300.00(+63.2%) | -$28.70 K(-54.7%) |
| Mar 2009 | - | -$5700.00(-119.8%) | -$63.40 K(-74.8%) |
| Dec 2008 | $42.00 M(+59.0%) | $28.80 K(-167.8%) | -$251.40 K(-53.8%) |
| Sep 2008 | - | -$42.50 K(-3.4%) | -$544.50 K(-54.6%) |
| Jun 2008 | - | -$44.00 K(-77.3%) | -$1.20 M(-31.5%) |
| Mar 2008 | - | -$193.70 K(-26.7%) | -$1.75 M(+8.1%) |
| Dec 2007 | $26.42 M(-241.7%) | -$264.30 K(-62.1%) | -$1.62 M(+13.1%) |
| Sep 2007 | - | -$697.10 K(+17.2%) | -$1.43 M(+68.4%) |
| Jun 2007 | - | -$594.60 K(+857.5%) | -$849.40 K(+221.9%) |
| Mar 2007 | - | -$62.10 K(-18.8%) | -$263.90 K(+25.2%) |
| Dec 2006 | -$18.65 M(-80.5%) | -$76.50 K(-34.2%) | -$210.80 K(+22.6%) |
| Sep 2006 | - | -$116.20 K(+1176.9%) | -$172.00 K(+205.0%) |
| Jun 2006 | - | -$9100.00(+1.1%) | -$56.40 K(+13.3%) |
| Mar 2006 | - | -$9000.00(-76.1%) | -$49.80 K(+2.0%) |
| Dec 2005 | -$95.58 M(+219.2%) | -$37.70 K(+6183.3%) | -$48.80 K(-75.9%) |
| Sep 2005 | - | -$600.00(-76.0%) | -$202.20 K(-51.6%) |
| Jun 2005 | - | -$2500.00(-68.8%) | -$417.50 K(-6.3%) |
| Mar 2005 | - | -$8000.00(-95.8%) | -$445.80 K(-1.1%) |
| Dec 2004 | -$29.94 M(-751.7%) | -$191.10 K(-11.5%) | -$450.60 K(+66.8%) |
| Sep 2004 | - | -$215.90 K(+601.0%) | -$270.10 K(+396.5%) |
| Jun 2004 | - | -$30.80 K(+140.6%) | -$54.40 K(+54.1%) |
| Mar 2004 | - | -$12.80 K(+20.8%) | -$35.30 K(-65.7%) |
| Dec 2003 | $4.59 M(-109.3%) | -$10.60 K(+5200.0%) | -$103.00 K(-52.1%) |
| Sep 2003 | - | -$200.00(-98.3%) | -$214.90 K(+0.1%) |
| Jun 2003 | - | -$11.70 K(-85.5%) | -$214.60 K(+4.5%) |
| Mar 2003 | - | -$80.50 K(-34.3%) | -$205.30 K(+64.5%) |
| Dec 2002 | -$49.15 M(-1700.8%) | -$122.50 K(<-9900.0%) | -$124.80 K(+1173.5%) |
| Sep 2002 | - | $100.00(-104.2%) | -$9800.00(-1.0%) |
| Jun 2002 | - | -$2400.00(<-9900.0%) | -$9900.00(+32.0%) |
| Mar 2002 | - | $0.00(-100.0%) | -$7500.00(+5.6%) |
| Dec 2001 | $3.07 M(-137.5%) | -$7500.00(<-9900.0%) | -$7100.00(-13.4%) |
| Sep 2001 | - | $0.00(0.0%) | -$8200.00(-58.8%) |
| Jun 2001 | - | $0.00(-100.0%) | -$19.90 K(0.0%) |
| Mar 2001 | - | $400.00(-104.7%) | -$19.90 K(-2.0%) |
| Dec 2000 | -$8.20 M(+11.5%) | -$8600.00(-26.5%) | -$20.30 K(+73.5%) |
| Sep 2000 | - | -$11.70 K(<-9900.0%) | -$11.70 K(<-9900.0%) |
| Jun 2000 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2000 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 1999 | -$7.35 M(-613.9%) | $0.00(0.0%) | $0.00(-100.0%) |
| Sep 1999 | - | $0.00(0.0%) | $197.60 K(-252.1%) |
| Jun 1999 | - | $0.00(0.0%) | -$129.90 K(-35.1%) |
| Mar 1999 | - | $0.00(-100.0%) | -$200.30 K(+54.2%) |
| Dec 1998 | $1.43 M(-227.9%) | $197.60 K(-160.3%) | -$129.90 K(-20.3%) |
| Sep 1998 | - | -$327.50 K(+365.2%) | -$162.90 K(+38.4%) |
| Jun 1998 | - | -$70.40 K(-200.0%) | -$117.70 K(-101.9%) |
| Mar 1998 | - | $70.40 K(-57.2%) | $6.12 M(-148.4%) |
| Dec 1997 | -$1.12 M(+155.4%) | $164.60 K(-158.3%) | -$12.65 M(-1.3%) |
| Sep 1997 | - | -$282.30 K(-104.6%) | -$12.81 M(+2.3%) |
| Jun 1997 | - | $6.17 M(-133.0%) | -$12.53 M(-33.0%) |
| Mar 1997 | - | -$18.70 M | -$18.70 M |
| Dec 1996 | -$437.80 K | - | - |
FAQ
- What is COSCIENS Biopharma annual cash flow from investing activities?
- What is the all time high annual CFI for COSCIENS Biopharma?
- What is COSCIENS Biopharma annual CFI year-on-year change?
- What is COSCIENS Biopharma quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for COSCIENS Biopharma?
- What is COSCIENS Biopharma quarterly CFI year-on-year change?
- What is COSCIENS Biopharma TTM cash flow from investing activities?
- What is the all time high TTM CFI for COSCIENS Biopharma?
- What is COSCIENS Biopharma TTM CFI year-on-year change?
What is COSCIENS Biopharma annual cash flow from investing activities?
The current annual CFI of CSCI is $528.00 K
What is the all time high annual CFI for COSCIENS Biopharma?
COSCIENS Biopharma all-time high annual cash flow from investing activities is $42.00 M
What is COSCIENS Biopharma annual CFI year-on-year change?
Over the past year, CSCI annual cash flow from investing activities has changed by +$540.00 K (+4500.00%)
What is COSCIENS Biopharma quarterly cash flow from investing activities?
The current quarterly CFI of CSCI is $83.00 K
What is the all time high quarterly CFI for COSCIENS Biopharma?
COSCIENS Biopharma all-time high quarterly cash flow from investing activities is $25.88 M
What is COSCIENS Biopharma quarterly CFI year-on-year change?
Over the past year, CSCI quarterly cash flow from investing activities has changed by +$687.30 K (+113.73%)
What is COSCIENS Biopharma TTM cash flow from investing activities?
The current TTM CFI of CSCI is $24.79 M
What is the all time high TTM CFI for COSCIENS Biopharma?
COSCIENS Biopharma all-time high TTM cash flow from investing activities is $24.79 M
What is COSCIENS Biopharma TTM CFI year-on-year change?
Over the past year, CSCI TTM cash flow from investing activities has changed by +$25.53 M (+3453.81%)